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Background: Older children have higher SARS-CoV-2 infection rates than younger children. We investigated
SARS-CoV-2 infection, seroprevalence and seroconversion rates in staff and students following the full
reopening of all secondary schools in England.
Methods: Public Health England (PHE) invited secondary schools in six regions (East and West London, Hert-
fordshire, Derbyshire, Manchester and Birmingham) to participate in SARS-CoV-2 surveillance during the
2020/21 academic year. Participants had nasal swabs for RT-PCR and blood samples for SARS-CoV-2 antibod-
ies at the beginning (September 2020) and end (December 2020) of the autumn term. Multivariable logistic
regression was used to assess independent risk factors for seropositivity and seroconversion.
Findings: Eighteen schools in six regions enrolled 2,209 participants, including 1,189 (53.8%) students and
1,020 (46.2%) staff. SARS-CoV-2 infection rates were not significantly different between students and staff in
round one (5/948; [0.53%] vs. 2/876 [0.23%]; p = 0.46) or round two (10/948 [1.05%] vs. 7/886 [0.79%];
p = 0.63), and similar to national prevalence. None of four and 7/15 (47%) sequenced strains in rounds 1 and 2
were the highly transmissible SARS-CoV-2 B.1.1.7 variant. In round 1, antibody seropositivity was higher in
students than staff (114/893 [12.8%] vs. 79/861 [9.2%]; p = 0.016), but similar in round 2 (117/893 [13.1%]
vs.117/872 [13.3%]; p = 0.85), comparable to local community seroprevalence. Between the two rounds, 8.7%
(57/652) staff and 6.6% (36/549) students seroconverted (p = 0.16).
Interpretation: In secondary schools, SARS-CoV-2 infection, seropositivity and seroconversion rates were sim-
ilar in staff and students, and comparable to local community rates. Ongoing surveillance will be important
for monitoring the impact of new variants in educational settings.
Funding: This surveillance was funded by the Department of Health and Social Care (DHSC).
Crown Copyright © 2021 Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/)er Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)1. Introduction
The emergence and rapid spread of SARS-CoV-2, the virus respon-
sible for COVID-19, in December 2019 forced many countries to
impose national lockdown to control the pandemic [13]. In England,
Research in context
Evidence before this study
Some reports suggested larger outbreaks affecting staff and stu-
dents in secondary schools compared to primary schools.
Recent observations studies following the full reopening of
schools in the US and Europe have reported COVID-19 cases in
staff and students, but very little evidence of in-school trans-
mission. Most reports involved passive surveillance, with test-
ing of symptomatic individuals for acute infection followed by
active case finding to identify secondary cases.
Added value of this study
We found infection rates among secondary school staff and stu-
dents were similar to community infection rates at the begin-
ning (September 2020) and end (December 2020) of the
autumn term. None of the strains at the beginning of term and
half the sequenced strains at the end of term belonged to the
highly transmissible and more aggressive B.1.1.7 variant. Anti-
body positivity rates were higher in students than staff at the
beginning of term but similar 9 weeks later, and comparable to
local community seroprevalence. Seroconversion rates during
the autumn term were also similar between staff and students,
and associated with number of positive cases in school, but not
with size of school or size of class.
Implications of all the available evidence
SARS-CoV-2 infection and seroprevalence rates in secondary
school staff and students were comparable to community rates,
but higher than primary schools and lower than other institu-
tional settings, such as care homes, hospitals or prisons. The
emergence of the B.1.1.7 variant of concern in December 2020
will require close monitoring when schools reopen after the lat-
est national lockdown in March 2020.
2 S.N. Ladhani et al. / EClinicalMedicine 37 (2021) 100948the first imported cases of COVID-19 were confirmed at the end of
January 2021 and increased rapidly from early March 2021, leading
to school closures on 20 March 2020, followed by wider lockdown on
23 March 2020 [4]. Cases continued to increase until mid-April before
plateauing and declined until the end of May 2020 [5]. From 01 June
2020, preschools, some primary and two secondary school years par-
tially reopened for face-to-face teaching as part of the easing of
national lockdown [6]. Strict infection control practices were imple-
mented in schools, including physical distancing, hand and surface
sanitisation, and smaller class sizes organised into bubbles that did
not physically or socially interact with each other [6]. Very few infec-
tions and outbreaks were identified in educational settings during
the summer half-term [7], and, along with similar positive experien-
ces in other countries that reopened after their national lockdown
[2,8], led to the full reopening of all schools in September 2020 [6].
Secondary school-aged children have higher SARS-CoV-2 infec-
tion rates than primary school-aged children [9], with larger and
more extensive COVID-19 outbreaks reported in secondary schools
compared to primary schools [1012]. We, therefore, initiated pro-
spective surveillance in 18 schools across six English regions to assess
the risk of SARS-CoV-2 infection in students and staff from September
2020 until the end of the autumn term in December 2020. In addition
to nasal swabs to test for acute SARS-CoV-2 infection, we collected
blood samples to test for SARS-CoV-2 antibodies, which provide a
more robust measure of prior symptomatic, asymptomatic or mild,
transient SARS-CoV-2 infection. We compared antibody seropreva-
lence in participating schools with local community rates andestimated seroconversion rates and risk factors for seroconversions
among seronegative students and staff.
2. Methods
The COVID-19 Surveillance in Secondary School KIDs (sKIDsPLUS)
protocol is available online ( HYPERLINK '' https://www.gov.uk/guid-
ance/covid-19-paediatric-surveillance) [13]. The protocol was
approved by PHE Research Ethics Governance Group (reference
Nr0228; 24 August 2020). The study involved testing secondary
school students for SARS-CoV-2 infection and antibodies at the start
(22 September17 October) and end (317 December) of the
autumn term of the 2020/21 academic year. Schools were
approached in areas where a paediatric investigation team could be
assembled: Derbyshire, West London, East London, Greater Manches-
ter, Hertfordshire and Birmingham.
The schools were open full-time for in-person teaching, albeit
strict infection control measures in place and very limited extracur-
ricular or after-school activities for students [6]. As per national guid-
ance, face masks and face coverings were not recommended in
classrooms, but staff and children in secondary schools were advised
to wear them in communal areas outside the classroom if physical
distancing was difficult to maintain [6]. Headteachers in participating
schools emailed the study information pack to staff, parents of stu-
dents aged <16 years and students aged 16. Participants or their
parent/guardian provided informed consent online via Snap Survey,
and completed a short questionnaire prior to the sampling day. The
questionnaire requested information about demographics, risk fac-
tors and COVID-19 symptoms or confirmed infections in the house-
hold. Enrolment was open for new participants between rounds 1
and 2. Headteachers in participating schools provided information
about average bubble sizes, school absences (>10 days), numbers iso-
lating at home and confirmed cases in students and staff for the term.
A team of clinicians, nurses, phlebotomists and administrative staff
attended the school on the sampling days. Local anaesthetic cream
was offered to all students before blood sampling. A member of the
school staff was present with each student. Participating students
and staff had a nasal swab and a blood sample taken by the investiga-
tion team.
2.1. Laboratory testing
The swabs were tested by a triplex reverse transcription quantita-
tive PCR (RT-qPCR) assay for the detection of ORF1ab and E gene
regions of SARS-CoV-2 with simultaneous detection of an exogenous
internal control using the Applied Biosystems Quantstudio 7-flex
thermocycler (ThermoFisher Scientific, UK). The ORF1ab gene pri-
mers/probes published by the China CDC were combined with the E
gene primers/probe published Corman et al. [14,15]. A positive RT-
qPCR result was reported to the participant, local investigator, head
teacher and local PHE health protection team (HPT), typically within
48 hours of the sample being taken. The participant and household
members self-isolated as per national guidance. Public health risk
assessment was undertaken with the school to decide additional
measures, including identification and isolation of the participant’s
contacts inside and outside school premises. Serology was performed
on the Abbott Architect using a chemiluminescent microparticle
immunoglobulin G (IgG) immunoassay targeting the nucleoprotein
(SARS-CoV-2 IgG, Abbott Commerce Chicago, USA) with a seroposi-
tivity threshold of 0.8 [16].
2.2. Statistical analysis
Data were managed in R-Studio and Microsoft Access and ana-
lysed in Stata SE (version 15.1). Data that did not follow a normal dis-
tribution are described as median with interquartile ranges.
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Chi2-test or Fisher’s exact. SARS-CoV-2 infection rate and antibody
seroprevalence, with 95% confidence intervals (CI), were compared
between secondary school students and staff and the Office for
National Statistics (ONS) Coronavirus Infection Survey regional sero-
prevalence (spike protein antibody target) for the corresponding
time periods [17,18]. Non-overlapping 95% CIs were used to assess
statistical significance between student or staff rates and ONS esti-
mates. Antibody seroconversion rates with 95% confidence intervals
were calculated for participants who were tested in both rounds and
were negative in their first round of testing.
Tests for association with participant drop-out at round 2, SARS-
CoV-2 antibody positivity and antibody seroconversion were per-
formed using logistic regression. To assess the characteristics of stu-
dents and staff who dropped out in round 2, univariate and
multivariable logistic regression was used, adjusted for sex, age, eth-
nicity, school area and Round 1 antibody test results. Participants
were classified as included in each round if they provided a blood or
swab sample in that round. Univariable analysis including all partici-
pants was performed initially, followed by a multivariable analysis
including participants with complete data. For SARS-CoV-2 antibody
positivity and antibody seroconversion, a multivariable regression
model was built using age, sex, ethnicity and school area a priori, and
factors found to be associated with SARS-CoV-2 antibody positivity
or antibody seroconversion in the univariable analysis. Variation
between schools was allowed for via a school-level random effect.
2.3. Role of funding source
The funder of the study had no role in study design, data collec-
tion, data analysis, data interpretation, or writing of the report. SNLTable 1




Male 765 (34.6) 645 (35.3)
Female 1436 (65.0) 1174 (64.3)
Non-binary 6 (0.3) 4 (0.2)
Not known 2 (0.1) 2 (0.1)
Age category
11-12 399 (18.1) 325 (17.8)
13-14 478 (21.6) 381 (20.9)
15-16 170 (7.7) 135 (7.4)
17-18 142 (6.4) 107 (5.9)
19-29 185 (8.4) 161 (8.8)
30-39 280 (12.7) 243 (13.3)
40-49 250 (11.3) 219 (12.0)
50-59 255 (11.5) 211 (11.6)
60+ 50 (2.3) 43 (2.4)
Ethnicity
White 1577 (71.4) 1325 (72.6)
Black 97 (4.4) 77 (4.2)
Asian 333 (15.1) 256 (14.0)
Mixed 125 (5.7) 103 (5.6)
Other 59 (2.7) 51 (2.8)
Unknown 18 (0.8) 13 (0.7)
School Area
Derbyshire 552 (25.0) 456 (25.0)
East London 531 (24.0) 423 (23.2)
Greater Manchester 173 (7.8) 145 (7.9)
Hertfordshire 171 (7.7) 167 (9.2)
West London 333 (15.1) 248 (13.6)
Birmingham 449 (20.3) 386 (21.2)
Median (IQR) number of participants by school 108 (80-120)
Total 2,209 1825
IQR: interquartile rangeand GI had access to the data and had final responsibility to submit
for publication.
3. Results
Eighteen secondary schools in six school areas enrolled and all
participated in both rounds of sKIDsPLUS. In round 1, there were
1,825 participants, comprising of 948 (51.9%) students and 877
(48.1%) staff (Supplementary Fig. S1, Table 1). In round 2, 367 partic-
ipants did not return for their second test (239 [25.2%] students, 128
[14.6%] staff) and 384 new participants (241 students, 143 staff) were
enrolled, resulting in 1,842 participants (950 [51.6%] students, 892
[48.4%] staff) in round 2. The demographics of participants in the two
rounds were similar (Table 1), but drop out between rounds 1 and 2
was associated with Asian ethnicity and school area in students, and
school area and being aged 3039 years in staff (Supplementary
Table S2).
3.1. SARS-CoV-2 infection rates
Nasal swabs for SARS-CoV-2 RT-qPCR in round 1 were positive in
0.38% (7/1,824; 95% CI, 0.150.79) participants and were not signifi-
cantly different between students (5/948; 0.53%, 95% CI: 0.171.23)
and staff (2/876; 0.23%, 95% CI: 0.030.82; p = 0.46) (Table 2). In
round 2, SARS-CoV-2 RT-qPCR positivity was 0.93 (17/1834; 95% CI,
0.54-1.48) and, again, did not differ significantly between students
(10/948; 1.05%; 95% CI: 0.511.93) and staff (7/886; 0.79%; 95% CI:
0.321.62; p = 0.63). These were similar to national infection rates
for the corresponding time periods in the ONS Coronavirus Infection
Survey for round 1 (0.21%; 95% CI: 0.180.24) and round 2 (1.18; 95%
CI:1.121.25). Where known (13/17, 76.5%), 38.5% (5/13) ofIDs Plus in the autumn term, 2020.
Round 1 Round 2
Students Staff Total Students Staff
373 (39.3) 272 (31.0) 625 (33.9) 362 (38.1) 263 (29.5)
569 (60.0) 605 (69.0) 1212 (65.8) 583 (61.4) 629 (70.5)
4 (0.4) 0 (0.0) 4 (0.2) 4 (0.4) 0 (0.0)
2 (0.2) 0 (0.0) 1 (0.1) 1 (0.2) 0 (0.0)
325 (34.3) 314 (17.0) 314 (33.1)
381 (40.2) 376 (20.4) 376 (39.6)
135 (14.2) 139 (7.5) 139 (14.6)
107 (11.3) 121 (6.6) 121 (12.7)
161 (18.4) 169 (9.2) 169 (18.9)
243 (27.7) 236 (12.8) 236 (26.5)
219 (25.0) 216 (11.7) 216 (24.2)
211 (24.1) 226 (12.3) 226 (25.3)
43 (4.9) 45 (2.4) 45 (5.0)
608 (64.1) 717 (81.8) 1342 (72.9) 623 (65.6) 719 (80.6)
43 (4.5) 34 (3.9) 77 (4.2) 44 (4.6) 33 (3.7)
170 (17.9) 86 (9.8) 258 (14.0) 158 (16.6) 100 (11.2)
78 (8.2) 25 (2.9) 104 (5.6) 80 (8.4) 24 (2.7)
38 (4.0) 13 (1.5) 46 (2.5) 33 (3.5) 13 (1.5)
11 (1.2) 2 (0.2) 15 (0.8) 12 (1.3) 3 (0.3)
213 (22.5) 243 (27.7) 448 (24.3) 209 (22.0) 239 (26.8)
224 (23.6) 199 (22.7) 420 (22.8) 222 (23.4) 198 (22.2)
87 (9.2) 58 (6.6) 139 (7.5) 82 (8.6) 57 (6.4)
102 (10.8) 65 (7.4) 132 (7.2) 75 (7.9) 57 (6.4)
146 (15.4) 102 (11.6) 300 (16.3) 188 (19.8) 112 (12.6)
176 (18.6) 210 (24.0) 403 (21.9) 174 (18.3) 229 (25.7)
102 (82-122)
948 877 1842 950 892
Table 2
SARS-COV-2 PCR and antibody results in students and staff from 18 schools participating in sKIDs Plus
in round 1 (September) and round 2 (December).
Round 1 Round 2
Total Students Staff Total Students Staff
PCR results
Negative 1,817 (99.6) 943 (99.5) 874 (99.8) 1,817 (99.1) 938 (98.9) 879 (99.2)
Positive 7 (0.4) 5 (0.5) 2 (0.2) 17 (0.9) 10 (1.1) 7 (0.8)
Total 1,824 948 876 1,834 948 886
Antibody results
Negative 1,561 (89.0) 779 (87.2) 782 (90.8) 1,531 (86.7) 776 (86.9) 755 (86.6)
Positive 193 (11.0) 114 (12.8) 79 (9.2) 234 (13.3) 117 (13.1) 117 (13.4)
Total 1,754 893 861 1,765 893 872
4 S.N. Ladhani et al. / EClinicalMedicine 37 (2021) 100948participants positive in round 2 reported COVID-19 symptoms
between testing rounds, 4 within a week of their positive test, the
other had tested positive for SARS-CoV-2 almost a month earlier.
3.2. SARS-CoV-2 genome sequencing
Four (57.1%) and 15 (88.2%) positive samples from rounds 1 and 2,
respectively, were successfully sequenced. None were the B1.1.7 vari-
ant in round 1 compared to seven (46.7%) in round 2, including four
in London, two in the Birmingham and one in Derbyshire.
3.3. Antibody prevalence
SARS-CoV-2 antibody positivity was 11.0% (193/1754; 95%CI:
9.612.6) in round 1 and 13.3% (234/1765; 95% CI: 11.714.9;
p = 0.041) in round 2 (Table 2). In round 1, antibody positivity was
higher in students (114/893 [12.8%], 95% CI: 10.615.1) than staff
(79/861 [9.2%], 95% CI: 7.311.3; p = 0.016), but similar in round 2
(students: 117/893 [13.1%], 95% CI: 11.015.5; staff: 117/872 [13.4%],
95% CI: 11.215.9; p = 0.85). Significant changes in antibody positiv-
ity between the two rounds were only observed for staff (p = 0.005),
not students (p = 0.83). Differences in antibody positivity were
observed by school area in rounds 1 (p < 0.001) and 2 (p = 0.001).
When compared to local community seroprevalence, antibody posi-
tivity in students was higher in West London and Hertfordshire in
round 1 and lower for both students and staff in East London in round
2 (Fig. 1).
Multivariable regression, adjusted for all other variables in the
model and clustering by school, was used to assess predictors of anti-
body positivity in rounds 1 and 2 (Tables 3,4). Clustering by school
was not significant for students in either round and only significant
for staff in round 1 (p = 0.0088). In round 1 antibody positivity in stu-
dents was associated with school area, year group and additional
children in the household and, in round 2, with Black ethnicity and
the number of positive cases in the school. In staff, antibody positivity
in round 1 was associated with being male and, in round 2, with eth-
nicity and the number of positive cases in the school during the
autumn term.
3.4. Seroconversion
Overall, 61.6% (1360/2209) of participants had antibody results for
both rounds of testing, including 1,201 (88.3%) who were negative in
round 1 (Fig. 2). The median time between testing rounds was 9.3
weeks (IQR: 9.111). The seroconversion rate was 7.7% (93/1201;
95% CI: 6.39.4) and did not differ between staff (57/652, 8.7%, 95%
CI: 6.711.2) and students (36/549, 6.6%, 95% CI: 4.69.0) (p = 0.16)
but differed by school area (p < 0.001). Where known (91/93, 97.8%),
COVID-19 symptoms among participants who seroconverted
between the two rounds were reported in 33.3% (12/36) of students
compared to 76.4% (42/55) of staff (p < 0.001). When asked, 60.4%(29/48) of staff completing the questionnaire considered that they
had acquired the infection in school compared to (36.4% (12/33) of
students (p = 0.033), and 16.7% (8/48) and 36.4% (12/33), respectively,
had not known they were infected over the autumn term. More par-
ticipants (60.9%; 28/46) who were positive and reported COVID-19
symptoms between testing rounds thought they acquired the infec-
tion at school than participants who reported no COVID-19 symp-
toms (37.1%; 13/35; p = 0.034). Using multivariable logistic
regression, seroconversion in students and staff was associated with
the number of positive cases in the school during the autumn term
and for staff was additionally associated with Black ethnicity and the
number of children in the household, but not with size of the house-
hold, healthcare or other key workers in the household, school or
class size, or proportion of students on free school meals (Supple-
mentary Tables S3 and S4).
4. Discussion
Active prospective surveillance following full reopening of sec-
ondary schools in England identified acute SARS-CoV-2 infection in
0.38% and 0.93% of participants at the start and end of the autumn
term of the 2020/21 academic year. While infection rates were higher
in students than in staff in both rounds, the differences were not sta-
tistically significant. Genome sequencing identified nearly half the
SARS-CoV-2 strains in December 2020 as the novel B1.1.7 variant
compared to none in September 2020. At the start of the autumn
term, SARS-CoV-2 antibody positivity rates were significantly higher
at 12.8% in students compared to 9.2% in staff but similar at 13.1%
and 13.4%, respectively at a median of 9.3 weeks later. Antibody sero-
prevalence rates in students and staff were generally similar to
regional community rates, both at the start and end of the Autumn
term, albeit with wide confidence intervals. Among participants who
were seronegative at the start of the autumn term, seroconversion
rates were 6.6% in students and 8.7% in staff by the end of term. Sero-
conversion was significantly associated with the number of positive
cases in school during the autumn term. Around 33.3% of students
who seroconverted reported COVID-19 symptoms compared to
76.4% among staff (p < 0.001).
The UK experience following full reopening of all school years in
the autumn term was different to the partial reopening of some pri-
mary and secondary school years in the previous summer mini-term
[7]. Nationally, SARS-CoV-2 infection rates were higher across all
age-groups including children, and there were more infections and
outbreaks reported in educational settings during the autumn term
[9,19]. Using the same methodology in primary schools, the SARS-
CoV-2 antibody seroconversion rate was 5% among staff and students
[20], and a lower proportion of primary schools than secondary
schools experienced a COVID-19 outbreak during the first half of the
autumn term.
An important question to consider is whether the infections occur
within or outside the school premises. We have consistently found
S.N. Ladhani et al. / EClinicalMedicine 37 (2021) 100948 5that SARS-CoV-2 infection rates in school-aged children correlated
with local community infection rates in adults, during periods of high
and low community infection prevalence, during school holidays and
after partial and full reopening of schools in England [7,9]. During the
summer months, when schools were closed, older teenagers and
young adults had some of the highest SARS-CoV-2 infection rates in
England [9]. In the current surveillance, too, we observed high infec-
tion and antibody seropositivity rates among secondary school stu-
dents at the start of the autumn term, indicating that they hadFig. 1. Student, staff and community prevalence (percent) of SARS-COV-2 antibodies for the
tistics, 2021, Coronavirus (COVID-19) Infection Survey, antibody data for the UK: 16 March 202
[18] (a) Round 1 (September). (b) Round 2 (December).acquired the infection in the community. Higher community infec-
tion rates allow more opportunities for virus introduction into educa-
tional settings.
The reopening of schools, especially full reopening of all school
years, will increase the risk of SARS-CoV-2 infection, because of
increased person-to-person contact inside and outside school prem-
ises (public transport, families gathering during school drop-offs and
pick-ups, etc.), which in-turn will have a small but measurable
impact on the reproduction number for SARS-CoV-2 [21]. There is,six school areas in rounds 1 and 2. Community prevalence source: Office for National Sta-
1. (data from 17 September to 14 October 2020 and 10 December 2020 to 6 January 2021.
Table 3
Risk factors for antibody positivity in students participating rounds 1 (a) and 2 (b) of secondary school surveillance for SARS-CoV-2, England.
OR = odds ratio; IQR = Interquartile Range; CI = confidence interval.
a)
Antibody positive Univariable analysis Multivariable analysis adjusted for clustering by school (p = 1.0)
N = 893 N = 719
Factor n/N (%) OR (95% CI) P value OR (95% CI) P value
Sex
Female 63/532 (11.8) REF REF 0.86
Male 51/355 (14.4) 1.25 (0.841.86) 0.27 1.05 (0.631.73)
Nonbinary/Missing 0/6 (0.0)
Year Group
Years 79 56/475 (11.8) REF 0.013 REF 0.0031
Years 1011 43/241 (17.8) 1.62 (1.062.50) 2.31 (1.373.88)
6th form/College 15/177 (8.5) 0.69 (0.381.26) 0.97 (0.462.02)
Ethnicity
White 63/567 (11.1) REF 0.01 REF 0.15
Black 10/41 (24.4) 2.58 (1.215.51) 1.99 (0.735.46)
Asian 24/164 (14.6) 1.37 (0.832.27) 1.38 (0.732.61)
Mixed 7/73 (9.6) 0.85 (0.371.93) 1.04 (0.422.55)
Other 10/37 (27.0) 2.96 (1.376.41) 2.74 (1.156.54)
Missing 0/11 (0.0)
School area
Derbyshire 15/205 (7.3) 0.93 (0.422.04) 0.0042 0.85 (0.312.33) 0.012
East London 35/215 (16.3) 2.28 (1.144.56) 2.39 (0.975.93)
Greater Manchester 9/80 (11.3) 1.49 (0.603.70) 2.03 (0.715.85)
Hertfordshire 15/98 (15.3) 2.12 (0.954.75) 2.63 (0.977.10)
West London 28/142 (19.7) 2.89 (1.405.93) 3.33 (1.397.99)
Birmingham 12/153 (7.8) REF REF
Additional children in household
per additional child 0.75 (0.580.97) 0.027 0.77 (0.591.00) 0.048
median size (IQR) 1 (02)
Additional household members
per additional member 0.98 (0.861.11) 0.72
median size (IQR) 3 (34)
Parental occupation
Neither healthcare or key worker 71/570 (12.5) REF 0.77
Key worker 31/245 (12.7) 1.02 (0.651.60)
Healthcare worker 12/78 (15.4) 1.28 (0.662.48)
School Capacity
per 1 increase in students per year 1.00 (0.991.00) 0.18
median (IQR)* 1215 (7931500)
% FSM
per % increase in FSM 1.00 (0.981.02) 0.68
median (IQR) * 17.6 (9.220.7)
b)
Antibody positive Univariable analysis Multivariable analysis adjusted for clustering by school (p = 1.0)
N = 893 N = 878
Factor n/N (%) OR (95% CI) P value OR (95% CI) P value
Sex
Female 62/550 (11.3) REF REF 0.26
Male 55/339 (16.2) 1.52 (1.032.25) 0.035 1.31 (0.822.08)
Nonbinary/Missing 0/4 (0.0)
Year Group
Years 79 62/464 (13.4) REF 0.0031 REF 0.18
Years 1011 42/233 (18.0) 1.43 (0.932.19) 1.29 (0.822.04)
6th formCollege 13/196 (6.6) 0.46 (0.250.86) 0.64 (0.311.32)
Ethnicity
White 72/591 (12.2) REF 0.14 REF 0.053
Black 11/41 (26.8) 2.64 (1.275.50) 3.35 (1.527.38)
Asian 19/147 (12.9) 1.07 (0.621.84) 1.12 (0.612.05)
Mixed 10/72 (13.9) 1.16 (0.572.37) 1.32 (0.632.80)
Other 5/31 (16.1) 1.39 (0.523.72) 1.48 (0.534.12)
Missing 0/11 (0.0)
School area
Derbyshire 26/205 (12.7) 1.16 (0.602.25) 0.0071 1.20 (0.552.60) 0.60
East London 22/207 (10.6) 0.95 (0.481.88) 1.25 (0.542.93)
Greater Manchester 22/79 (27.8) 3.09 (1.516.32) 1.93 (0.864.34)
Hertfordshire 10/75 (13.3) 1.23 (0.532.86) 1.73 (0.575.19)
West London 21/183 (11.5) 1.04 (0.522.07) 1.45 (0.563.74)
West Midlands 16/144 (11.1) REF REF
Additional children in household
per additional child 0.94 (0.741.19) 0.57
median size (IQR) 1 (02)
Additional household members
per additional member 1.02 (0.871.18) 0.84
(continued)
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median size (IQR) 3 (34)
Parental occupation
Neither healthcare or key worker 79/576 (13.7) REF 0.53
Key worker 32/249 (12.9) 0.93 (0.601.44)
Healthcare worker 6/68 (8.8) 0.61 (0.251.45)
School Capacity
Per 10 student increase 1.01 (1.001.01) 0.049 1.00 (0.991.01) 0.79
Median size (IQR) * 1215 (7931380)
Average students year
per 1 increase in students per year 1.00 (1.001.00) 0.83
median (IQR) * 192 (160300)
% FSM
per % increase in FSM 1.03 (1.011.06) 0.001 1.01 (0.981.04) 0.60
median (IQR) * 17.5 (9.220.7)
Number of positive cases in school
per 1 additional case 1.01 (1.011.02) <0.001 1.01 (1.001.03) 0.027
median (IQR) * 35 (1556)
based on included students and not school
Table 4
Risk factors for antibody positivity in staff participating rounds 1 (a) and 2 (b) of secondary school surveillance for SARS-CoV-2, England.OR = odds ratio; IQR = Interquartile Range;
CI = confidence interval
a)
Antibody positive Univariable analysis Multivariable analysis adjusted for clustering by school (p = 0.0088)
N = 861 N = 857
Factor n/N (%) OR (95% CI) P value OR (95% CI) P value
Sex
Female 45/594 (7.6) REF 0.016 REF 0.010
Male 34/267 (12.7) 1.78 (1.112.85) 1.93 (1.173.19)
Year Group
1929 15/158 (9.5) 1.21 (0.602.47) 0.57 1.20 (0.582.51) 0.33
3039 19/239 (7.9) REF REF
4049 17/212 (8.0) 1.01 (0.512.00) 1.13 (0.552.30)
5059 25/209 (12.0) 1.57 (0.842.95) 1.95 (1.003.80)
60+ 3/43 (7.0) 0.87 (0.253.07) 1.16 (0.314.27)
Ethnicity
White 56/705 (7.9) REF 0.051 REF 0.30
Black 7/33 (21.2) 3.12 (1.307.51) 2.57 (0.966.90)
Asian 11/85 (12.9) 1.72 (0.863.43) 1.63 (0.773.45)
Mixed 4/24 (16.7) 2.32 (0.777.02) 1.79 (0.536.05)
Other 1/13 (7.7) 0.97 (0.127.56) 0.99 (0.128.23)
Missing 0/1 (0.0)
School area
Derbyshire 16/239 (6.7) 0.89 (0.431.85) 0.052 1.01 (0.313.29)
East London 19/196 (9.7) 1.33 (0.662.70) 1.18 (0.393.52)
Greater Manchester 6/58 (10.3) 1.43 (0.533.87) 1.97 (0.458.58) 0.77
Hertfordshire 5/65 (7.7) 1.03 (0.362.96) 1.27 (0.246.60)
North London 18/102 (17.6) 2.66 (1.285.53) 2.26 (0.667.75)
Birmingham 15/201 (7.5) REF REF
Additional household members
per additional member 0.97 (0.821.16) 0.77
median size (IQR) 2 (13)
Additional children in household
per additional child 0.91 (0.711.17) 0.48
median size (IQR) 0 (01)
Other household occupation
Neither healthcare or key worker 49/574 (8.5) REF 0.50
Key worker 26/259 (10.0) 1.20 (0.731.97)
Healthcare worker 4/28 (14.3) 1.79 (0.605.36)
School Capacity
Per 10 student increase 0.99 (0.991.00) 0.032 1.00 (0.991.01) 0.54
Median size (IQR) * 1300 (10751500)
% FSM
per % increase in FSM 1.01 (0.981.03) 0.56
median (IQR) * 19.7 (14.329.4)
omitted due to small sample size; * based on
included staff and not school
b)
Antibody positive Univariable analysis Multivariable analysis adjusted for clustering by school (p = 0.11)
N = 872 N = 870
Factor n/N (%) OR (95% CI) P value OR (95% CI) P value
Sex
Female 79/611 (12.9) REF 0.52 REF 0.23
(continued)
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Male 38/261 (14.6) 1.15 (0.761.74) 1.30 (0.842.02)
Year Group
1929 25/164 (15.2) 1.55 (0.852.83) 0.59 1.65 (0.893.08) 0.42
3039 24/231 (10.4) REF REF
4049 29/213 (13.6) 1.36 (0.762.42) 1.32 (0.732.39)
5059 33/219 (15.1) 1.53 (0.872.68) 1.70 (0.953.05)
60+ 6/45 (13.3) 1.33 (0.513.46) 1.25 (0.463.35)
Ethnicity
White 87/704 (12.4) REF 0.094 REF 0.011
Black 9/32 (28.1) 2.78 (1.246.19) 4.18 (1.7210.16)
Asian 17/97 (17.5) 1.51 (0.852.66) 2.07 (1.113.86)
Mixed 3/24 (12.5) 1.01 (0.303.47) 1.33 (0.374.74)
Other 1/13 (7.7) 0.59 (0.084.60) 0.76 (0.096.29)
Missing 0/2 (0.0)
School area
Derbyshire 37/235 (15.7) 0.96 (0.581.59) 0.058 0.94 (0.461.91) 0.49
East London 16/197 (8.1) 0.45 (0.240.85) 0.48 (0.201.14)
Greater Manchester 11/57 (19.3) 1.23 (0.582.61) 1.14 (0.423.06)
Hertfordshire 4/57 (7.0) 0.39 (0.131.14) 0.55 (0.152.06)
North London 14/111 (12.6) 0.74 (0.381.45) 1.02 (0.382.71)
West Midlands 35/215 (16.3) REF REF
Additional household members
per additional member 1.01 (0.881.17) 0.85
median size (IQR) 2 (13)
Additional children in household
per additional child 0 (01) 1.17 (0.971.42) 0.10
median size (IQR)
Other household occupation
Neither healthcare or key worker 70/587 (11.9) REF 0.18
Key worker 42/254 (16.5) 1.46 (0.972.21)
Healthcare worker 5/31 (16.1) 1.42 (0.533.82)
School Capacity
Per 10 student increase 1.00 (1.001.01) 0.61
Median size (IQR) * 1300 (10751500)
Ave year size
per 1 increase in students per year 1.00 (1.001.00) 0.73
median (IQR) * 197 (160300)
% FSM
per % increase in FSM 1.02 (1.001.04) 0.12
median (IQR) * 19.7 (14.329.4)
Number of positive cases in school
per 1 additional case 1.01 (1.011.02) <0.001 1.01 (1.001.02) 0.021
median (IQR) * 35 (1866)
Students a week
019 2/39 (5.1) 0.29 (0.071.25)
2099 6/67 (9.0) 0.52 (0.201.32) 0.23
100200 28/176 (15.9) REF
200+ 36/248 (14.5) 0.90 (0.521.54)
Missing 45/342 (13.2)
* based on included staff and not school
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sion within school premises is very low, [2224] especially among
students [19]. In North Carolina, for example, surveillance of 11
school districts with more than 90,000 students and staff attending
school in-person for 9 weeks, found 773 community-acquired SARS-
CoV-2 infections, while contact tracing found only 32 additional
infections that were acquired within school [24]. Among 17 rural
Wisconsin schools, too, COVID-19 incidence among 4,876 students
and 654 staff members during August 31November 29, 2020, was
lower (3,453 cases per 100,000) than in the county overall (5,466 per
100,000) [23]. Of the 191 cases identified in students and staff mem-
bers, only seven (3.7%), all among students, were linked to in-school
spread [23]. In New York City, COVID-19 prevalence in public schools
was similar to or less than estimates of prevalence in the community
for all weeks during October 9December 18, 2020 [25]. Additionally,
of 36,423 school-based close contacts, only 191 (0.5%) subsequently
tested positive for COVID-19 and the likely index case was an adult
for 78.0% of secondary cases [25]. Outside the US, public health inves-
tigations found that just over half the cases in secondary school clus-
ters in the Netherlands were acquired outside school, mainly during
intensive contact with friends or classmates in their free time, andmost infections were restricted to small groups of students without
affecting teachers [26]. These schools received extensive public
health support including contact tracing but, without regular screen-
ing of staff and students, asymptomatic infection and silent transmis-
sion with school premises could not be ruled out.
Nonetheless, school staff and parents remain apprehensive about
acquiring SARS-CoV-2 in school, especially from students who are
more likely to have asymptomatic infection [27]. Indeed, 60% of staff
and 36% of student Seroconverters believed they were infected with
SARS-CoV-2 at school when asked. Additionally, in secondary schools
was associated with the number of positive cases in school during
the autumn term and, at the end of the term, seropositivity rates
were similar among staff and students overall. Suggesting that at
least some of the infections occurred inside school premises. That
seroprevalence rates among staff and students were similar to local
community infections rates, however, is reassuring because, if wide-
spread silent transmission following asymptomatic infection was
occurring in schools, then seropositivity and seroconversion rates
would have been much higher than local community rates, as
reported in up to two-thirds of residents and staff in care homes, irre-
spective of symptom status or PCR-positivity [28]. Other institutional
Fig. 2. Results of the participants tested in both rounds of sKIDs Plus
S.N. Ladhani et al. / EClinicalMedicine 37 (2021) 100948 9settings including hospitals [29], prisons [30], and detention centres
[31] have also reported much higher antibody seroprevalence rates
during the current pandemic.
In secondary schools, we found no evidence of clustering of SARS-
CoV-2 RT-PCR positive cases or seroconversions among staff or stu-
dents, which would have indicated in-school transmission. Addition-
ally, neither the size of the school or class, nor the proportion of
students on free school meal (an indicator of socioeconomic status)
were associated with seroconversion among staff or students. Reas-
suringly, too, recent analyses by the UK ONS also found that teachers
were not at increased risk of COVID-19 or COVID-19 related deaths
compared to other professions [32].
It is likely that, although implemented with varying success in the
participating schools, the nationally-recommended infection control
measures are helping control the spread of the virus inside school
premises [6]. The contribution of the different infection control meas-
ures in preventing SARS-CoV-2 transmission is, however, not known
and requires further study. In UK secondary schools, for examples,
staff and students were only recommended to wear face coverings in
communal areas outside the classroom during the autumn term [6].
Following the emergence of new SARS-CoV-2 variants of concern in
December 2020, schools were closed as part of national lockdown
and, when they reopened fully on 08 March 2021, additional meas-
ures were recommended, including twice-weekly rapid testing for
staff and students and continuous use of face covering whilst in
school premises [33,34].
The strength of this surveillance lies in the rapid recruitment of
secondary schools to monitor SARS-CoV-2 infection and transmission
as soon as they reopened after national lockdown in September
2020. There were some limitations. We only recruited schools in
regions where we had paediatric investigation teams that were able
to take blood samples from large numbers of staff and students. Our
schools are, therefore, not intended to be representative of all sec-
ondary schools in England. In participating schools, we avoided
recruiting some secondary school years with end-of-year national
examinations to minimise disruption of their education, and, only a
proportion of staff and students consented to taking part insKIDsPLUS. We are also unable to comment on the transmissibility or
disease severity of B.1.1.7 variant because schools were closed as part
of national lockdown in mid-December as soon as cases started
increasing and did not fully reopen until March 2020 when commu-
nity SARS-CoV-2 infections rates were very low. Additionally, we
used the Abbott platform to measure nucleoprotein antibodies,
which develop quickly following infection but then wanes faster over
time than spike protein antibodies. As a result, some participants
infected with SARS-CoV-2 early in the pandemic may have serore-
verted using our selected antibody assay platform. Caution must be
taken when comparing with regional antibody seroprevalence in the
ONS Coronavirus Infection Survey, which tested for spike antibodies.
Finally, as already discussed, we were unable to assess whether the
confirmed infections occurred within or outside the school premises.
We are currently conducting a larger national School Infection Survey
(SIS) involving 150 schools across England during the 2020/21 aca-
demic year [35]. This survey will also include outbreak investigations
to better understand infection and transmission within educational
settings.
SARS-CoV-2 infection and seroconversion rates were higher in
secondary compared to primary school students following the full
reopening of all schools in England, but lower than other institutional
settings, likely because of the infection control measures that have
been implemented in educational settings. Keeping schools open
must remain a top priority for all countries and maintaining low com-
munity infection rates is critical for reducing opportunities for virus
introduction into educational settings.
The UK commitment to vaccinate all adults means that all school
staff and all parents will have been offered a COVID-19 vaccine before
the start of the 2021/22 academic year in September 2021. This will
not only help maintain low community infection rates down but also
protect both these groups should they be exposed to the virus.
Whether children should also be vaccinated against COVID-19 is
debatable and the UK, like any other country, will need to make a
decision when a vaccine is licensed for <16 year-olds. In the mean-
time, ongoing surveillance in educational settings will be important
for monitoring the impact of new variants in educational and other
institutional settings.Funding
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